Pharmaceuticals In India
- All
- News
- Videos
-
Union Budget 2026 Puts Healthcare Growth At Centre With Biopharma, Mental Health, Cancer Care Focus
The Union Budget presented by Finance Minister Nirmala Sitharaman in Parliament on Sunday on healthcare and pharmaceuticals pushed biopharma manufacturing, research, and skilled manpower.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
Healthcare And Pharmaceutical Wishlist For Union Budget 2026: Industry Insiders Seek Key Reforms
India is all set to witness the announcement of Union budget 2026-27. In this article, we explore what healthcare and pharma stakeholders are expecting from the Government to make healthcare delivery robust.
-
India-EU Trade Deal Opens Up Both Regions As Major Affordable Medicine Suppliers: Indian Pharmaceutical Alliance
Speaking on the significance of the agreement, Sudarshan Jain, General Secretary, Indian Pharmaceutical Alliance, said that the India-EU FTA is a landmark development, particularly for the pharmaceutical sector.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Chandrababu Naidu Showcases Andhra As Hub For Global Investments At Davos
Andhra Pradesh has initiated at least 25 new policies for industrial development and is encouraging investments in digital media and virtual production, Chief Minister N Chandrababu Naidu has said in multiple interactions in Davos.
-
Health Ministry Bans Nimesulide Oral Doses Above 100 Mg Over Safety Concerns
The government has banned the manufacture, sale and distribution of all oral formulations of pain and fever medications, containing Nimesulide above 100 milligrams in immediate release dosage form, with immediate effect.
-
"Kindly Relieve Me ASAP": Pharma Firm Finance Boss Quits Over Delhi Pollution
This resignation is seen as an unusual event in Indian corporate history, where an executive has cited environmental conditions as the reason for leaving.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
How Trump's Policy For Prescription Drugs Could Reshape Trade With India
US President Donald Trump's announcement of sweeping prescription drug price cuts under a "Most Favoured Nation" policy has put India's pharmaceutical industry in focus.
-
Cough Syrup Smuggling: Case Filed Against 12 More Pharmaceutical Firms In UP
The food and drugs department of the Uttar Pradesh government filed a case on Friday against 12 more pharmaceutical firms in connection with the codeine-containing cough syrup-smuggling case in Varanasi.
-
$100 Million Boost For India-Afghanistan Trade Marks Setback for Pakistan
In a significant development that signals a new phase of India-Afghanistan economic cooperation and a blow to Pakistan's regional trade influence, leading pharmaceutical companies from India and Afghanistan have signed a $100 million MoU.
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Safety Lapses, Weak Oversight Being Probed Into Cough Syrup Deaths: Report
Officials are investigating whether safety lapses in the supply of a pharmaceutical ingredient were responsible for contaminating cough syrup that has killed at least 24 children in recent months, according to three people familiar with the matter.
-
2 Killed, 20 Injured After Boiler Explosion At Pharma Factory In Gujarat
At least two workers were killed and 20 others injured after a boiler exploded and triggered a major fire at a pharmaceutical factory in the Bharuch district of Gujarat in the wee hours of Wednesday, an official said.
-
Union Budget 2026 Puts Healthcare Growth At Centre With Biopharma, Mental Health, Cancer Care Focus
The Union Budget presented by Finance Minister Nirmala Sitharaman in Parliament on Sunday on healthcare and pharmaceuticals pushed biopharma manufacturing, research, and skilled manpower.
-
US Revives Drug Origin Debate, Cites Indian Exports
US renewed a push to require country-of-origin labeling on prescription drugs, citing temporary restrictions on pharmaceutical exports during the Covid pandemic by India as evidence that America's drug supply remains vulnerable to foreign disruptions
-
Healthcare And Pharmaceutical Wishlist For Union Budget 2026: Industry Insiders Seek Key Reforms
India is all set to witness the announcement of Union budget 2026-27. In this article, we explore what healthcare and pharma stakeholders are expecting from the Government to make healthcare delivery robust.
-
India-EU Trade Deal Opens Up Both Regions As Major Affordable Medicine Suppliers: Indian Pharmaceutical Alliance
Speaking on the significance of the agreement, Sudarshan Jain, General Secretary, Indian Pharmaceutical Alliance, said that the India-EU FTA is a landmark development, particularly for the pharmaceutical sector.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Chandrababu Naidu Showcases Andhra As Hub For Global Investments At Davos
Andhra Pradesh has initiated at least 25 new policies for industrial development and is encouraging investments in digital media and virtual production, Chief Minister N Chandrababu Naidu has said in multiple interactions in Davos.
-
Health Ministry Bans Nimesulide Oral Doses Above 100 Mg Over Safety Concerns
The government has banned the manufacture, sale and distribution of all oral formulations of pain and fever medications, containing Nimesulide above 100 milligrams in immediate release dosage form, with immediate effect.
-
"Kindly Relieve Me ASAP": Pharma Firm Finance Boss Quits Over Delhi Pollution
This resignation is seen as an unusual event in Indian corporate history, where an executive has cited environmental conditions as the reason for leaving.
-
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.
-
How Trump's Policy For Prescription Drugs Could Reshape Trade With India
US President Donald Trump's announcement of sweeping prescription drug price cuts under a "Most Favoured Nation" policy has put India's pharmaceutical industry in focus.
-
Cough Syrup Smuggling: Case Filed Against 12 More Pharmaceutical Firms In UP
The food and drugs department of the Uttar Pradesh government filed a case on Friday against 12 more pharmaceutical firms in connection with the codeine-containing cough syrup-smuggling case in Varanasi.
-
$100 Million Boost For India-Afghanistan Trade Marks Setback for Pakistan
In a significant development that signals a new phase of India-Afghanistan economic cooperation and a blow to Pakistan's regional trade influence, leading pharmaceutical companies from India and Afghanistan have signed a $100 million MoU.
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
Safety Lapses, Weak Oversight Being Probed Into Cough Syrup Deaths: Report
Officials are investigating whether safety lapses in the supply of a pharmaceutical ingredient were responsible for contaminating cough syrup that has killed at least 24 children in recent months, according to three people familiar with the matter.
-
2 Killed, 20 Injured After Boiler Explosion At Pharma Factory In Gujarat
At least two workers were killed and 20 others injured after a boiler exploded and triggered a major fire at a pharmaceutical factory in the Bharuch district of Gujarat in the wee hours of Wednesday, an official said.
